Raymond F Anton

TitleEndowed Chair, Strom Thurmond Wellness and fitness Endowed Chair
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
454N
67 President St.
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Anton is a Distinguished University Professor and senior investigator with over 25 years of research experience. He is considered an international expert in biologic markers of alcohol use as well as in new treatments for alcohol use disorders (AUD's), as evidenced by conducting over 15 clinical trials. He participated in PROJECT Match as well as being the chair of the COMBINE Study and first author of its publication in JAMA. His team also developed one of he first fMRI alcohol cue tasks showing activation in salient brain reward systems that could be blocked by medications. As a current holder of a Senior Scientist Career and Mentoring Award (K05) he has used that support to integrate genetics and neuroimaging into his clinical trial work. His group has begun to bring together the brain-imaging paradigm with genetics and pharmacogenetics, providing the best technology available to investigate alcohol effects on the human brain as they relate to alcoholism vulnerability and treatment.
    Collapse keywords
    Alcohol, Substance Use, Brain, Genetics, Stage II, Stage III, Drug Studies

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Schacht JP, Hoffman M, Voronin KE, Book SW, Anton RF. Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Neuropsychopharmacology. 2022 Oct; 47(11):1953-1960. PMID: 35523943.
      Citations:    
    2. Ekhtiari H, Zare-Bidoky M, Sangchooli A, Janes AC, Kaufman MJ, Oliver JA, Prisciandaro JJ, Wüstenberg T, Anton RF, Bach P, Baldacchino A, Beck A, Bjork JM, Brewer J, Childress AR, Claus ED, Courtney KE, Ebrahimi M, Filbey FM, Ghahremani DG, Azbari PG, Goldstein RZ, Goudriaan AE, Grodin EN, Hamilton JP, Hanlon CA, Hassani-Abharian P, Heinz A, Joseph JE, Kiefer F, Zonoozi AK, Kober H, Kuplicki R, Li Q, London ED, McClernon J, Noori HR, Owens MM, Paulus MP, Perini I, Potenza M, Potvin S, Ray L, Schacht JP, Seo D, Sinha R, Smolka MN, Spanagel R, Steele VR, Stein EA, Steins-Loeber S, Tapert SF, Verdejo-Garcia A, Vollstädt-Klein S, Wetherill RR, Wilson SJ, Witkiewitz K, Yuan K, Zhang X, Zilverstand A. A methodological checklist for fMRI drug cue reactivity studies: development and expert consensus. Nat Protoc. 2022 03; 17(3):567-595. PMID: 35121856.
      Citations:    
    3. Aldridge AP, Zarkin GA, Dowd WN, Witkiewitz K, Hasin DS, O'Malley SS, Isenberg K, Anton RF. The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup. J Addict Med. 2022 Jul-Aug 01; 16(4):425-432. PMID: 34864785.
      Citations:    
    4. Schacht JP, Hoffman M, Chen BH, Anton RF. Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial. Pharmacogenomics J. 2022 02; 22(1):1-8. PMID: 34381173.
      Citations:    
    5. Biernacka JM, Coombes BJ, Batzler A, Ho AM, Geske JR, Frank J, Hodgkinson C, Skime M, Colby C, Zillich L, Pozsonyiova S, Ho MF, Kiefer F, Rietschel M, Weinshilboum R, O'Malley SS, Mann K, Anton R, Goldman D, Karpyak VM. Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study. Neuropsychopharmacology. 2021 11; 46(12):2132-2139. PMID: 34302059.
      Citations:    
    6. Prisciandaro JJ, Hoffman M, Brown TR, Voronin K, Book S, Bristol E, Anton RF. Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial. Am J Psychiatry. 2021 09 01; 178(9):829-837. PMID: 34256607.
      Citations:    
    7. Shmulewitz D, Aharonovich E, Witkiewitz K, Anton RF, Kranzler HR, Scodes J, Mann KF, Wall MM, Hasin D. The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013. Am J Psychiatry. 2021 06; 178(6):548-559. PMID: 33472388.
      Citations:    
    8. Witkiewitz K, Kranzler HR, Hallgren KA, Hasin DS, Aldridge AP, Zarkin GA, Mann KF, O'Malley SS, Anton RF. Stability of Drinking Reductions and Long-term Functioning Among Patients with Alcohol Use Disorder. J Gen Intern Med. 2021 02; 36(2):404-412. PMID: 33180306.
      Citations:    
    9. Anton RF, Hoffman M. Changed Primary Outcome Between Trial Registration and Publication-Reply. JAMA Intern Med. 2020 11 01; 180(11):1551-1552. PMID: 32677668.
      Citations:    
    10. Anton RF, Voronin KE, Book SW, Latham PK, Randall PK, Glen WB, Hoffman M, Schacht JP. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2020 10; 44(10):2084-2096. PMID: 32772383.
      Citations:    
    11. Sakran JV, Mehta A, Matar MM, Wilson DA, Kent AJ, Anton RF, Fakhry SM. The Utility of Carbohydrate-Deficient Transferrin in Identifying Chronic Alcohol Users in the Injured Patient: Expanding the Toolkit. J Surg Res. 2021 01; 257:92-100. PMID: 32818790.
      Citations:    
    12. Meredith LR, Maralit AM, Thomas SE, Rivers SL, Salazar CA, Anton RF, Tomko RL, Squeglia LM. Piloting of the Just Say Know prevention program: a psychoeducational approach to translating the neuroscience of addiction to youth. Am J Drug Alcohol Abuse. 2021 01 02; 47(1):16-25. PMID: 32687415.
      Citations:    
    13. Knox J, Scodes J, Witkiewitz K, Kranzler HR, Mann K, O'Malley SS, Wall M, Anton R, Hasin DS. Reduction in World Health Organization Risk Drinking Levels and Cardiovascular Disease. Alcohol Clin Exp Res. 2020 08; 44(8):1625-1635. PMID: 32619058.
      Citations:    
    14. Anton RF, Latham P, Voronin K, Book S, Hoffman M, Prisciandaro J, Bristol E. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2020 05 01; 180(5):728-736. PMID: 32150232.
      Citations:    
    15. Witkiewitz K, Heather N, Falk DE, Litten RZ, Hasin DS, Kranzler HR, Mann KF, O'Malley SS, Anton RF. World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom. Addiction. 2020 09; 115(9):1668-1680. PMID: 32056311.
      Citations:    
    16. Hartwell EE, Feinn R, Morris PE, Gelernter J, Krystal J, Arias AJ, Hoffman M, Petrakis I, Gueorguieva R, Schacht JP, Oslin D, Anton RF, Kranzler HR. Systematic review and meta-analysis of the moderating effect of rs1799971 in OPRM1, the mu-opioid receptor gene, on response to naltrexone treatment of alcohol use disorder. Addiction. 2020 08; 115(8):1426-1437. PMID: 31961981.
      Citations:    
    17. Anton RF, Witkiewitz K, Falk D, Litten R, Hasin D, Mann K, O'Malley S. Response to Dr. Mark Litt's Commentary. Alcohol Clin Exp Res. 2019 10; 43(10):2255-2256. PMID: 31381170.
      Citations:    
    18. Prisciandaro JJ, Schacht JP, Prescot AP, Brenner HM, Renshaw PF, Brown TR, Anton RF. Intraindividual changes in brain GABA, glutamate, and glutamine during monitored abstinence from alcohol in treatment-naive individuals with alcohol use disorder. Addict Biol. 2020 11; 25(6):e12810. PMID: 31373138.
      Citations:    
    19. Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk DE, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS. Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population. Drug Alcohol Depend. 2019 08 01; 201:16-22. PMID: 31174140.
      Citations:    
    20. Prisciandaro JJ, Schacht JP, Prescot AP, Brenner HM, Renshaw PF, Brown TR, Anton RF. Evidence for a unique association between fronto-cortical glycine levels and recent heavy drinking in treatment naïve individuals with alcohol use disorder. Neurosci Lett. 2019 07 27; 706:207-210. PMID: 31108129.
      Citations:    
    21. Ballester MP, Marti-Aguado D, Fullana M, Bosca-Watts MM, Tosca J, Romero E, Sanchez A, Navarro-Cortes P, Anton R, Mora F, Minguez M. Impact and risk factors of non-adherence to 5-aminosalicylates in quiescent ulcerative colitis evaluated by an electronic management system. Int J Colorectal Dis. 2019 Jun; 34(6):1053-1059. PMID: 30963247.
      Citations:    
    22. Witkiewitz K, Falk DE, Litten RZ, Hasin DS, Kranzler HR, Mann KF, O'Malley SS, Anton RF. Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2019 05; 43(5):979-987. PMID: 30951210.
      Citations:    
    23. Falk DE, O'Malley SS, Witkiewitz K, Anton RF, Litten RZ, Slater M, Kranzler HR, Mann KF, Hasin DS, Johnson B, Meulien D, Ryan M, Fertig J. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials. JAMA Psychiatry. 2019 04 01; 76(4):374-381. PMID: 30865232.
      Citations:    
    24. Knox J, Scodes J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Anton R, Hasin DS. Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population. Drug Alcohol Depend. 2019 04 01; 197:228-235. PMID: 30852375.
      Citations:    
    25. Prisciandaro JJ, Schacht JP, Prescot AP, Renshaw PF, Brown TR, Anton RF. Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers. Alcohol Clin Exp Res. 2019 02; 43(2):221-226. PMID: 30537347.
      Citations:    
    26. Witkiewitz K, Kranzler HR, Hallgren KA, O'Malley SS, Falk DE, Litten RZ, Hasin DS, Mann KF, Anton RF. Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder. Alcohol Clin Exp Res. 2018 12; 42(12):2453-2465. PMID: 30395350.
      Citations:    
    27. Knox J, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Anton R, Hasin DS. Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population. Alcohol Clin Exp Res. 2018 11; 42(11):2256-2265. PMID: 30204248.
      Citations:    
    28. Schacht JP, Anton RF, McNamara PJ, Im Y, King AC. The dopamine transporter VNTR polymorphism moderates the relationship between acute response to alcohol and future alcohol use disorder symptoms. Addict Biol. 2019 09; 24(5):1109-1118. PMID: 30230123.
      Citations:    
    29. Stewart SH, Reuben A, Anton RF. Reply: Carbohydrate Deficient Transferrin in Patients with Cirrhosis: A Tale of Bridges. Alcohol Alcohol. 2018 05 01; 53(3):351-352. PMID: 29462240.
      Citations:    
    30. Kearney-Ramos TE, Dowdle LT, Lench DH, Mithoefer OJ, Devries WH, George MS, Anton RF, Hanlon CA. Transdiagnostic Effects of Ventromedial Prefrontal Cortex Transcranial Magnetic Stimulation on Cue Reactivity. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 07; 3(7):599-609. PMID: 29776789.
      Citations:    
    31. Anton RF, Latham PK, Voronin KE, Randall PK, Book SW, Hoffman M, Schacht JP. Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcohol Clin Exp Res. 2018 Apr; 42(4):751-760. PMID: 29431852.
      Citations:    
    32. Schacht JP, Voronin KE, Randall PK, Anton RF. Dopaminergic Genetic Variation Influences Aripiprazole Effects on Alcohol Self-Administration and the Neural Response to Alcohol Cues in a Randomized Trial. Neuropsychopharmacology. 2018 05; 43(6):1247-1256. PMID: 29362512.
      Citations:    
    33. Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 12; 42(13):2654. PMID: 29123234.
      Citations:    
    34. Matar MM, Jewett B, Fakhry SM, Wilson DA, Ferguson PL, Anton RF, Sakran JV. Identifying chronic heavy alcohol use in emergency general surgery patients: a pilot study. Trauma Surg Acute Care Open. 2017; 2(1):e000098. PMID: 29766097.
      Citations:    
    35. Prisciandaro JJ, Tolliver BK, Prescot AP, Brenner HM, Renshaw PF, Brown TR, Anton RF. Unique prefrontal GABA and glutamate disturbances in co-occurring bipolar disorder and alcohol dependence. Transl Psychiatry. 2017 07 04; 7(7):e1163. PMID: 28675386.
      Citations:    
    36. Anton RF, Schacht JP, Voronin KE, Randall PK. Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control. Alcohol Clin Exp Res. 2017 Jul; 41(7):1370-1380. PMID: 28493623.
      Citations:    
    37. Hanlon CA, Dowdle LT, Correia B, Mithoefer O, Kearney-Ramos T, Lench D, Griffin M, Anton RF, George MS. Left frontal pole theta burst stimulation decreases orbitofrontal and insula activity in cocaine users and alcohol users. Drug Alcohol Depend. 2017 09 01; 178:310-317. PMID: 28686990.
      Citations:    
    38. Hasin DS, Wall M, Witkiewitz K, Kranzler HR, Falk D, Litten R, Mann K, O'Malley SS, Scodes J, Robinson RL, Anton R. Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population. Lancet Psychiatry. 2017 06; 4(6):469-476. PMID: 28456501.
      Citations:    
    39. Schacht JP, Randall PK, Latham PK, Voronin KE, Book SW, Myrick H, Anton RF. Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. Neuropsychopharmacology. 2017 Dec; 42(13):2640-2653. PMID: 28409564.
      Citations:    
    40. Witkiewitz K, Wilson AD, Pearson MR, Hallgren KA, Falk DE, Litten RZ, Kranzler HR, Mann KF, Hasin DS, O'Malley SS, Anton RF. Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study. Alcohol Clin Exp Res. 2017 May; 41(5):1054-1062. PMID: 28295414.
      Citations:    
    41. Helander A, Wielders J, Anton R, Arndt T, Bianchi V, Deenmamode J, Jeppsson JO, Whitfield JB, Weykamp C, Schellenberg F. Reprint of Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT). Clin Chim Acta. 2017 Apr; 467:15-20. PMID: 28322729.
      Citations:    
    42. Witkiewitz K, Hallgren KA, Kranzler HR, Mann KF, Hasin DS, Falk DE, Litten RZ, O'Malley SS, Anton RF. Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels. Alcohol Clin Exp Res. 2017 01; 41(1):179-186. PMID: 28019652.
      Citations:    
    43. Schellenberg F, Wielders J, Anton R, Bianchi V, Deenmamode J, Weykamp C, Whitfield J, Jeppsson JO, Helander A. IFCC approved HPLC reference measurement procedure for the alcohol consumption biomarker carbohydrate-deficient transferrin (CDT): Its validation and use. Clin Chim Acta. 2017 Feb; 465:91-100. PMID: 28025028.
      Citations:    
    44. Stewart SH, Reuben A, Anton RF. Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease. Alcohol Alcohol. 2017 Jan; 52(1):24-28. PMID: 27998920.
      Citations:    
    45. Hahn JA, Anton RF, Javors MA. The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice. Alcohol Clin Exp Res. 2016 11; 40(11):2292-2295. PMID: 27716960.
      Citations:    
    46. Post A, Smart TS, Jackson K, Mann J, Mohs R, Rorick-Kehn L, Statnick M, Anton R, O'Malley SS, Wong CJ. Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence. Alcohol Clin Exp Res. 2016 09; 40(9):1935-44. PMID: 27435979.
      Citations:    
    47. Hallgren KA, Witkiewitz K, Kranzler HR, Falk DE, Litten RZ, O'Malley SS, Anton RF. Missing Data in Alcohol Clinical Trials with Binary Outcomes. Alcohol Clin Exp Res. 2016 07; 40(7):1548-57. PMID: 27254113.
      Citations:    
    48. Helander A, Wielders J, Anton R, Arndt T, Bianchi V, Deenmamode J, Jeppsson JO, Whitfield JB, Weykamp C, Schellenberg F. Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT). Clin Chim Acta. 2016 Aug 01; 459:19-24. PMID: 27221205.
      Citations:    
    49. Boyd SJ, Schacht JP, Prisciandaro JJ, Voronin K, Anton RF. Alcohol-Induced Stimulation Mediates the Effect of a GABRA2 SNP on Alcohol Self-Administrated among Alcohol-Dependent Individuals. Alcohol Alcohol. 2016 Sep; 51(5):549-54. PMID: 27117237.
      Citations:    
    50. McHugh RK, Fitzmaurice GM, Griffin ML, Anton RF, Weiss RD. Association between a brief alcohol craving measure and drinking in the following week. Addiction. 2016 06; 111(6):1004-10. PMID: 26780476.
      Citations:    
    51. Prisciandaro JJ, Schacht JP, Prescot AP, Renshaw PF, Brown TR, Anton RF. Associations Between Recent Heavy Drinking and Dorsal Anterior Cingulate N-Acetylaspartate and Glutamate Concentrations in Non-Treatment-Seeking Individuals with Alcohol Dependence. Alcohol Clin Exp Res. 2016 Mar; 40(3):491-6. PMID: 26853538.
      Citations:    
    52. Tolliver BK, Anton RF. Assessment and treatment of mood disorders in the context of substance abuse. Dialogues Clin Neurosci. 2015 Jun; 17(2):181-90. PMID: 26246792.
      Citations:    
    53. Witkiewitz K, Falk DE, Kranzler HR, Litten RZ, Hallgren KA, O'Malley SS, Anton RF. Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials. Alcohol Clin Exp Res. 2014 Nov; 38(11):2826-34. PMID: 25421518.
      Citations:    
    54. Anton RF. Commentary on: ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res. 2014 Jul; 38(7):1826-8. PMID: 24961935.
      Citations:    
    55. Stewart SH, Koch DG, Willner IR, Anton RF, Reuben A. Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease. Alcohol Clin Exp Res. 2014 Jun; 38(6):1706-11. PMID: 24848614.
      Citations:    
    56. Weykamp C, Wielders J, Helander A, Anton RF, Bianchi V, Jeppsson JO, Siebelder C, Whitfield JB, Schellenberg F. Harmonization of measurement results of the alcohol biomarker carbohydrate-deficient transferrin by use of the toolbox of technical procedures of the International Consortium for Harmonization of Clinical Laboratory Results. Clin Chem. 2014 Jul; 60(7):945-53. PMID: 24691685.
      Citations:    
    57. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals. Psychopharmacology (Berl). 2014 Sep; 231(18):3799-807. PMID: 24647921.
      Citations:    
    58. Greenfield TK, Ye Y, Bond J, Kerr WC, Nayak MB, Kaskutas LA, Anton RF, Litten RZ, Kranzler HR. Risks of alcohol use disorders related to drinking patterns in the U.S. general population. J Stud Alcohol Drugs. 2014 Mar; 75(2):319-27. PMID: 24650826.
      Citations:    
    59. Falk DE, Litten RZ, Anton RF, Kranzler HR, Johnson BA. Cumulative proportion of responders analysis (CPRA) as a tool to assess treatment outcome in alcohol clinical trials. J Stud Alcohol Drugs. 2014 Mar; 75(2):335-46. PMID: 24650828.
      Citations:    
    60. Ray LA, Bujarski S, Squeglia LM, Ashenhurst JR, Anton RF. Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol Alcohol. 2014 May-Jun; 49(3):261-70. PMID: 24421289.
      Citations:    
    61. Anton RF, Schacht JP, Book SW. Pharmacologic treatment of alcoholism. Handb Clin Neurol. 2014; 125:527-42. PMID: 25307594.
      Citations:    
    62. Gelernter J, Kranzler HR, Sherva R, Almasy L, Koesterer R, Smith AH, Anton R, Preuss UW, Ridinger M, Rujescu D, Wodarz N, Zill P, Zhao H, Farrer LA. Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci. Mol Psychiatry. 2014 Jan; 19(1):41-9. PMID: 24166409.
      Citations:    
    63. Anton RF. Commentary on Subbaraman et al. (2013) [corrected]: cravings as a mediator and moderator of drinking outcomes in the COMBINE Study. Addiction. 2013 Oct; 108(10):1745-6. PMID: 24033779.
      Citations:    
    64. Wong CJ, Witcher J, Mallinckrodt C, Dean RA, Anton RF, Chen Y, Fijal BA, Ouyang H, Dharia S, Sundseth SS, Schuh KJ, Kinon BJ. A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence. Alcohol Clin Exp Res. 2014 Feb; 38(2):511-20. PMID: 24010675.
      Citations:    
    65. Weykamp C, Wielders JP, Helander A, Anton RF, Bianchi V, Jeppsson JO, Siebelder C, Whitfield JB, Schellenberg F. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible. Clin Chem Lab Med. 2013 May; 51(5):991-6. PMID: 23241602.
      Citations:    
    66. DeSantis SM, Bandyopadhyay D, Baker NL, Randall PK, Anton RF, Prisciandaro JJ. Modeling longitudinal drinking data in clinical trials: an application to the COMBINE study. Drug Alcohol Depend. 2013 Sep 01; 132(1-2):244-50. PMID: 23566774.
      Citations:    
    67. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl). 2013 Jun; 227(4):627-37. PMID: 23389755.
      Citations:    
    68. Mann K, Lemenager T, Hoffmann S, Reinhard I, Hermann D, Batra A, Berner M, Wodarz N, Heinz A, Smolka MN, Zimmermann US, Wellek S, Kiefer F, Anton RF. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol. 2013 Nov; 18(6):937-46. PMID: 23231446.
      Citations:    
    69. Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S, Myrick H. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues. Neuropsychopharmacology. 2013 Feb; 38(3):414-22. PMID: 23032071.
      Citations:    
    70. Zhang H, Herman AI, Kranzler HR, Anton RF, Zhao H, Zheng W, Gelernter J. Array-based profiling of DNA methylation changes associated with alcohol dependence. Alcohol Clin Exp Res. 2013 Jan; 37 Suppl 1:E108-15. PMID: 22924764.
      Citations:    
    71. Zhang H, Herman AI, Kranzler HR, Anton RF, Simen AA, Gelernter J. Hypermethylation of OPRM1 promoter region in European Americans with alcohol dependence. J Hum Genet. 2012 Oct; 57(10):670-5. PMID: 22914673.
      Citations:    
    72. Bakhireva LN, Cano S, Rayburn WF, Savich RD, Leeman L, Anton RF, Savage DD. Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women. Alcohol Alcohol. 2012 Nov-Dec; 47(6):683-7. PMID: 22878591.
      Citations:    
    73. Zhang H, Wang F, Kranzler HR, Anton RF, Gelernter J. Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses. Behav Brain Funct. 2012 May 16; 8:23. PMID: 22591552.
      Citations:    
    74. Schacht JP, Anton RF, Myrick H. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol. 2013 Jan; 18(1):121-33. PMID: 22574861.
      Citations:    
    75. Anton RF, Voronin KK, Randall PK, Myrick H, Tiffany A. Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes. Alcohol Clin Exp Res. 2012 Nov; 36(11):2000-7. PMID: 22551036.
      Citations:    
    76. Han S, Yang BZ, Kranzler HR, Oslin D, Anton R, Farrer LA, Gelernter J. Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans. Biol Psychiatry. 2012 Oct 15; 72(8):637-44. PMID: 22520967.
      Citations:    
    77. Li D, Zhao H, Kranzler HR, Oslin D, Anton RF, Farrer LA, Gelernter J. Association of COL25A1 with comorbid antisocial personality disorder and substance dependence. Biol Psychiatry. 2012 Apr 15; 71(8):733-40. PMID: 22297151.
      Citations:    
    78. Chen J, Brunzell DH, Jackson K, van der Vaart A, Ma JZ, Payne TJ, Sherva R, Farrer LA, Gejman P, Levinson DF, Holmans P, Aggen SH, Damaj I, Kuo PH, Webb BT, Anton R, Kranzler HR, Gelernter J, Li MD, Kendler KS, Chen X. ACSL6 is associated with the number of cigarettes smoked and its expression is altered by chronic nicotine exposure. PLoS One. 2011; 6(12):e28790. PMID: 22205969.
      Citations:    
    79. Xie P, Kranzler HR, Zhang H, Oslin D, Anton RF, Farrer LA, Gelernter J. Childhood adversity increases risk for nicotine dependence and interacts with a5 nicotinic acetylcholine receptor genotype specifically in males. Neuropsychopharmacology. 2012 Feb; 37(3):669-76. PMID: 22012472.
      Citations:    
    80. Kranzler HR, Feinn R, Nelson EC, Covault J, Anton RF, Farrer L, Gelernter J. A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women. Am J Med Genet B Neuropsychiatr Genet. 2011 Dec; 156B(8):960-8. PMID: 21998007.
      Citations:    
    81. Douglas K, Chan G, Gelernter J, Arias AJ, Anton RF, Poling J, Farrer L, Kranzler HR. 5-HTTLPR as a potential moderator of the effects of adverse childhood experiences on risk of antisocial personality disorder. Psychiatr Genet. 2011 Oct; 21(5):240-8. PMID: 21399568.
      Citations:    
    82. Ittiwut C, Yang BZ, Kranzler HR, Anton RF, Hirunsatit R, Weiss RD, Covault J, Farrer LA, Gelernter J. GABRG1 and GABRA2 variation associated with alcohol dependence in African Americans. Alcohol Clin Exp Res. 2012 Apr; 36(4):588-93. PMID: 21919924.
      Citations:    
    83. Chang SC, Xie P, Anton RF, De Vivo I, Farrer LA, Kranzler HR, Oslin D, Purcell SM, Roberts AL, Smoller JW, Uddin M, Gelernter J, Koenen KC. No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples. Mol Psychiatry. 2012 Mar; 17(3):239-41. PMID: 21912390.
      Citations:    
    84. Anton RF, Litten RZ, Falk DE, Palumbo JM, Bartus RT, Robinson RL, Kranzler HR, Kosten TR, Meyer RE, O'Brien CP, Mann K, Meulien D. The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders. Neuropsychopharmacology. 2012 Jan; 37(2):402-11. PMID: 21900883.
      Citations:    
    85. Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF. The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res. 2012 Mar; 36(3):385-94. PMID: 21895723.
      Citations:    
    86. Xie P, Kranzler HR, Krauthammer M, Cosgrove KP, Oslin D, Anton RF, Farrer LA, Picciotto MR, Krystal JH, Zhao H, Gelernter J. Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry. 2011 Sep 15; 70(6):528-36. PMID: 21683344.
      Citations:    
    87. Schacht JP, Randall PK, Waid LR, Baros AM, Latham PK, Wright TM, Myrick H, Anton RF. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res. 2011 Nov; 35(11):2030-8. PMID: 21631542.
      Citations:    
    88. Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011 Jul; 168(7):709-17. PMID: 21454917.
      Citations:    
    89. Han S, Yang BZ, Kranzler HR, Oslin D, Anton R, Gelernter J. Association of CHRNA4 polymorphisms with smoking behavior in two populations. Am J Med Genet B Neuropsychiatr Genet. 2011 Jun; 156B(4):421-9. PMID: 21445957.
      Citations:    
    90. Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H. Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach. Neuroimage. 2011 May 01; 56(1):61-8. PMID: 21316465.
      Citations:    
    91. Cui D, Zhang H, Yang BZ, Listman JB, Li D, Price LH, Carpenter LL, Tyrka AR, Anton RF, Kranzler HR, Gelernter J. Variation in NGFB is associated with primary affective disorders in women. Am J Med Genet B Neuropsychiatr Genet. 2011 Jun; 156B(4):401-12. PMID: 21294249.
      Citations:    
    92. Leventhal AM, Gelernter J, Oslin D, Anton RF, Farrer LA, Kranzler HR. Agitated depression in substance dependence. Drug Alcohol Depend. 2011 Jul 01; 116(1-3):163-9. PMID: 21277711.
      Citations:    
    93. Herman AI, Conner TS, Anton RF, Gelernter J, Kranzler HR, Covault J. Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics. Addict Biol. 2011 Jan; 16(1):124-32. PMID: 20192950.
      Citations:    
    94. Stewart SH, Comte-Walters S, Bowen E, Anton RF. Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series. Alcohol Clin Exp Res. 2010 Nov; 34(11):1956-60. PMID: 20659069.
      Citations:    
    95. Helander A, Wielders JP, Jeppsson JO, Weykamp C, Siebelder C, Anton RF, Schellenberg F, Whitfield JB. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II. Performance of a laboratory network running the HPLC candidate reference measurement procedure and evaluation of a candidate reference material. Clin Chem Lab Med. 2010 Nov; 48(11):1585-92. PMID: 21034250.
      Citations:    
    96. Myrick H, Li X, Randall PK, Henderson S, Voronin K, Anton RF. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics. J Clin Psychopharmacol. 2010 Aug; 30(4):365-72. PMID: 20571434.
      Citations:    
    97. Sherva R, Kranzler HR, Yu Y, Logue MW, Poling J, Arias AJ, Anton RF, Oslin D, Farrer LA, Gelernter J. Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology. 2010 Aug; 35(9):1921-31. PMID: 20485328.
      Citations:    
    98. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Farrer LA, Gelernter J. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology. 2010 Jul; 35(8):1684-92. PMID: 20393453.
      Citations:    
    99. Anton RF. Editorial commentary: alcohol biomarker papers. Alcohol Clin Exp Res. 2010 Jun; 34(6):939-40. PMID: 20374210.
      Citations:    
    100. Vergne DE, Anton RF. Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence. CNS Neurol Disord Drug Targets. 2010 Mar; 9(1):50-4. PMID: 20201815.
      Citations:    
    101. Anton R. Substance abuse is a disease of the human brain: focus on alcohol. J Law Med Ethics. 2010; 38(4):735-44. PMID: 21105937.
      Citations:    
    102. Xie P, Kranzler HR, Poling J, Stein MB, Anton RF, Brady K, Weiss RD, Farrer L, Gelernter J. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry. 2009 Nov; 66(11):1201-9. PMID: 19884608.
      Citations:    
    103. Douglas KR, Chan G, Gelernter J, Arias AJ, Anton RF, Weiss RD, Brady K, Poling J, Farrer L, Kranzler HR. Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addict Behav. 2010 Jan; 35(1):7-13. PMID: 19720467.
      Citations:    
    104. Niciu MJ, Chan G, Gelernter J, Arias AJ, Douglas K, Weiss R, Anton RF, Farrer L, Cubells JF, Kranzler HR. Subtypes of major depression in substance dependence. Addiction. 2009 Oct; 104(10):1700-9. PMID: 19681804.
      Citations:    
    105. Anton RF, Myrick H, Baros AM, Latham PK, Randall PK, Wright TM, Stewart SH, Waid R, Malcolm R. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42. PMID: 19593171.
      Citations:    
    106. Miller PM, Cluver J, Anton RF. A useful test for monitoring alcohol use. Behav Healthc. 2009 Jun; 29(6):38, 40. PMID: 19655583.
      Citations:    
    107. Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8. PMID: 19485969.
      Citations:    
    108. Kranzler HR, Gelernter J, Anton RF, Arias AJ, Herman A, Zhao H, Burian L, Covault J. Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence. Alcohol Clin Exp Res. 2009 May; 33(5):925-30. PMID: 19320626.
      Citations:    
    109. Zuo L, Luo X, Listman JB, Kranzler HR, Wang S, Anton RF, Blumberg HP, Stein MB, Pearlson GD, Covault J, Charney DS, van Kammen DP, Price LH, Lappalainen J, Cramer J, Krystal JH, Gelernter J. Population admixture modulates risk for alcohol dependence. Hum Genet. 2009 Jun; 125(5-6):605-13. PMID: 19306106.
      Citations:    
    110. Farrer LA, Kranzler HR, Yu Y, Weiss RD, Brady KT, Anton R, Cubells JF, Gelernter J. Association of variants in MANEA with cocaine-related behaviors. Arch Gen Psychiatry. 2009 Mar; 66(3):267-74. PMID: 19255376.
      Citations:    
    111. LoCastro JS, Youngblood M, Cisler RA, Mattson ME, Zweben A, Anton RF, Donovan DM. Alcohol treatment effects on secondary nondrinking outcomes and quality of life: the COMBINE study. J Stud Alcohol Drugs. 2009 Mar; 70(2):186-96. PMID: 19261230.
      Citations:    
    112. Zhang H, Kranzler HR, Weiss RD, Luo X, Brady KT, Anton RF, Farrer LA, Gelernter J. Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry. 2009 Jul 15; 66(2):128-36. PMID: 19217079.
      Citations:    
    113. Oroszi G, Anton RF, O'Malley S, Swift R, Pettinati H, Couper D, Yuan Q, Goldman D. OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res. 2009 Mar; 33(3):383-93. PMID: 19053977.
      Citations:    
    114. Stewart SH, Oroszi G, Randall PK, Anton RF. COMT genotype influences the effect of alcohol on blood pressure: results from the COMBINE study. Am J Hypertens. 2009 Jan; 22(1):87-91. PMID: 19023276.
      Citations:    
    115. Stewart SH, Latham PK, Miller PM, Randall P, Anton RF. Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. Addiction. 2008 Oct; 103(10):1622-8. PMID: 18821872.
      Citations:    
    116. Luo X, Zuo L, Kranzler HR, Wang S, Anton RF, Gelernter J. Recessive genetic mode of an ADH4 variant in substance dependence in African-Americans: A model of utility of the HWD test. Behav Brain Funct. 2008 Sep 18; 4:42. PMID: 18801187.
      Citations:    
    117. Voronin K, Randall P, Myrick H, Anton R. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control. Alcohol Clin Exp Res. 2008 Nov; 32(11):1954-61. PMID: 18782344.
      Citations:    
    118. Anton RF. Naltrexone for the management of alcohol dependence. N Engl J Med. 2008 Aug 14; 359(7):715-21. PMID: 18703474.
      Citations:    
    119. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Addolorato G, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med. 2008 Jun 09; 168(11):1188-99. PMID: 18541827.
      Citations:    
    120. Anton RF. Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence. Pharmacogenomics. 2008 Jun; 9(6):655-8. PMID: 18518841.
      Citations:    
    121. Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry. 2008 Apr; 65(4):466-75. PMID: 18391135.
      Citations:    
    122. Baros AM, Latham PK, Anton RF. Naltrexone and cognitive behavioral therapy for the treatment of alcohol dependence: do sex differences exist? Alcohol Clin Exp Res. 2008 May; 32(5):771-6. PMID: 18336635.
      Citations:    
    123. Anton RF, Kranzler H, Breder C, Marcus RN, Carson WH, Han J. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. J Clin Psychopharmacol. 2008 Feb; 28(1):5-12. PMID: 18204334.
      Citations:    
    124. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry. 2008 Feb; 65(2):135-44. PMID: 18250251.
      Citations:    
    125. Donovan DM, Anton RF, Miller WR, Longabaugh R, Hosking JD, Youngblood M. Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): examination of posttreatment drinking outcomes. J Stud Alcohol Drugs. 2008 Jan; 69(1):5-13. PMID: 18080059.
      Citations:    
    126. Baros AM, Wright TM, Latham PK, Miller PM, Anton RF. Alcohol consumption, %CDT, GGT and blood pressure change during alcohol treatment. Alcohol Alcohol. 2008 Mar-Apr; 43(2):192-7. PMID: 18039674.
      Citations:    
    127. Bauer LO, Covault J, Harel O, Das S, Gelernter J, Anton R, Kranzler HR. Variation in GABRA2 predicts drinking behavior in project MATCH subjects. Alcohol Clin Exp Res. 2007 Nov; 31(11):1780-7. PMID: 17949392.
      Citations:    
    128. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007 Oct 10; 298(14):1641-51. PMID: 17925516.
      Citations:    
    129. Covault J, Gelernter J, Jensen K, Anton R, Kranzler HR. Markers in the 5'-region of GABRG1 associate to alcohol dependence and are in linkage disequilibrium with markers in the adjacent GABRA2 gene. Neuropsychopharmacology. 2008 Mar; 33(4):837-48. PMID: 17507911.
      Citations:    
    130. Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis DM, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnovitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007 Apr; 164(4 Suppl):5-123. PMID: 17569411.
      Citations:    
    131. Baros AM, Latham PK, Moak DH, Voronin K, Anton RF. What role does measuring medication compliance play in evaluating the efficacy of naltrexone? Alcohol Clin Exp Res. 2007 Apr; 31(4):596-603. PMID: 17374038.
      Citations:    
    132. Wright TM, Myrick H, Malcolm R, Randall P, Boyle E, Henderson S, Anton R. Impact of lifetime alcohol quit attempts and medicated detoxifications on time to relapse during an index alcohol detoxification. J Addict Med. 2007 Mar; 1(1):15-20. PMID: 21768927.
      Citations:    
    133. Cluver JS, Miller PM, Anton RF. Case studies of the utility of serum carbohydrate-deficient transferrin (%CDT) in the clinical management of alcoholics. J Addict Med. 2007 Mar; 1(1):44-7. PMID: 21768932.
      Citations:    
    134. Myrick H, Anton R, Voronin K, Wang W, Henderson S. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res. 2007 Feb; 31(2):221-7. PMID: 17250613.
      Citations:    
    135. Jeppsson JO, Arndt T, Schellenberg F, Wielders JP, Anton RF, Whitfield JB, Helander A. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med. 2007; 45(4):558-62. PMID: 17439340.
      Citations:    
    136. Ndjakou Lenta B, Vonthron-Sénécheau C, Fongang Soh R, Tantangmo F, Ngouela S, Kaiser M, Tsamo E, Anton R, Weniger B. In vitro antiprotozoal activities and cytotoxicity of some selected Cameroonian medicinal plants. J Ethnopharmacol. 2007 Apr 20; 111(1):8-12. PMID: 17141994.
      Citations:    
    137. Anton RF, Youngblood M. Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study. Alcohol Clin Exp Res. 2006 Nov; 30(11):1878-83. PMID: 17067352.
      Citations:    
    138. Pettinati HM, Anton RF, Willenbring ML. The COMBINE Study-: An Overview of the Largest Pharmacotherapy Study to Date for Treating Alcohol Dependence. Psychiatry (Edgmont). 2006 Oct; 3(10):36-9. PMID: 20877545.
      Citations:    
    139. Brady KT, Waldrop AE, McRae AL, Back SE, Saladin ME, Upadhyaya HP, Anton RF, Randall PK. The impact of alcohol dependence and posttraumatic stress disorder on cold pressor task response. J Stud Alcohol. 2006 Sep; 67(5):700-6. PMID: 16847538.
      Citations:    
    140. Kleber HD, Weiss RD, Anton RF, Rounsaville BJ, George TP, Strain EC, Greenfield SF, Ziedonis DM, Kosten TR, Hennessy G, O'Brien CP, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Nininger JE, Cook IA, Summergrad P, Finnerty MT, Woods SM, Johnson BR, Yager J, Pyles R, Lurie L, Cross CD, Walker RD, Peele R, Barnovitz MA, Gray SH, Shemo JP, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry. 2006 Aug; 163(8 Suppl):5-82. PMID: 16981488.
      Citations:    
    141. Brady KT, Back SE, Waldrop AE, McRae AL, Anton RF, Upadhyaya HP, Saladin ME, Randall PK. Cold pressor task reactivity: predictors of alcohol use among alcohol-dependent individuals with and without comorbid posttraumatic stress disorder. Alcohol Clin Exp Res. 2006 Jun; 30(6):938-46. PMID: 16737451.
      Citations:    
    142. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006 May 03; 295(17):2003-17. PMID: 16670409.
      Citations:    
    143. Miller PM, Spies C, Neumann T, Javors MA, Hoyumpa AM, Roache J, Webb A, Kashi M, Sharkey FE, Anton RF, Egan BM, Basile J, Nguyen S, Fleming MF, Dillie KS. Alcohol biomarker screening in medical and surgical settings. Alcohol Clin Exp Res. 2006 Feb; 30(2):185-93. PMID: 16441267.
      Citations:    
    144. Deas D, May MP, Randall C, Johnson N, Anton R. Naltrexone treatment of adolescent alcoholics: an open-label pilot study. J Child Adolesc Psychopharmacol. 2005 Oct; 15(5):723-8. PMID: 16262589.
      Citations:    
    145. Anton RF, Moak DH, Latham P, Waid LR, Myrick H, Voronin K, Thevos A, Wang W, Woolson R. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005 Aug; 25(4):349-57. PMID: 16012278.
      Citations:    
    146. Alling C, Chick JD, Anton R, Mayfield RD, Salaspuro M, Helander A, Harris RA. Revealing alcohol abuse: to ask or to test? Alcohol Clin Exp Res. 2005 Jul; 29(7):1257-63. PMID: 16088981.
      Citations:    
    147. Hosking JD, Cisler RA, Couper DJ, Gastfriend DR, Kivlahan DR, Anton RF. Design and analysis of trials of combination therapies. J Stud Alcohol Suppl. 2005 Jul; (15):34-42; discussion 33. PMID: 16223054.
      Citations:    
    148. Goldman D, Oroszi G, O'Malley S, Anton R. COMBINE genetics study: the pharmacogenetics of alcoholism treatment response: genes and mechanisms. J Stud Alcohol Suppl. 2005 Jul; (15):56-64; discussion 33. PMID: 16223057.
      Citations:    
    149. Weniger B, Vonthron-Sénécheau C, Kaiser M, Brun R, Anton R. Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids. Phytomedicine. 2006 Feb; 13(3):176-80. PMID: 16428025.
      Citations:    
    150. Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA. Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005 Jun; 7(6):346-51. PMID: 16088298.
      Citations:    
    151. Brady KT, Sonne S, Anton RF, Randall CL, Back SE, Simpson K. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar; 29(3):395-401. PMID: 15770115.
      Citations:    
    152. Weniger B, Vonthron-Sénécheau C, Arango GJ, Kaiser M, Brun R, Anton R. A bioactive biflavonoid from Campnosperma panamense. Fitoterapia. 2004 Dec; 75(7-8):764-7. PMID: 15567260.
      Citations:    
    153. Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF. Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res. 2004 Nov; 28(11):1710-7. PMID: 15547458.
      Citations:    
    154. Myrick H, Anton R. Recent advances in the pharmacotherapy of alcoholism. Curr Psychiatry Rep. 2004 Oct; 6(5):332-8. PMID: 15355755.
      Citations:    
    155. Fleming MF, Anton RF, Spies CD. A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels. Alcohol Clin Exp Res. 2004 Sep; 28(9):1347-55. PMID: 15365305.
      Citations:    
    156. Drobes DJ, Anton RF, Thomas SE, Voronin K. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcohol Clin Exp Res. 2004 Sep; 28(9):1362-70. PMID: 15365307.
      Citations:    
    157. Miller PM, Anton RF. Biochemical alcohol screening in primary health care. Addict Behav. 2004 Sep; 29(7):1427-37. PMID: 15345274.
      Citations:    
    158. Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S. A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol. 2004 Aug; 24(4):421-8. PMID: 15232334.
      Citations:    
    159. Labbate LA, Sonne SC, Randal CL, Anton RF, Brady KT. Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders? Compr Psychiatry. 2004 Jul-Aug; 45(4):304-10. PMID: 15224273.
      Citations:    
    160. Littleton JM, De Witte P, Litten R, Gessa GL, Spanagel R, Kranzler H, Lehert P, Johnson B, Saunders J, Berglund M, Harris A, Anton R, Mann K. Challenges to medications development in treating alcohol dependence: an international perspective. Alcohol Alcohol. 2004 Jul-Aug; 39(4):271-5. PMID: 15208155.
      Citations:    
    161. Miller PM, Ornstein SM, Nietert PJ, Anton RF. Self-report and biomarker alcohol screening by primary care physicians: the need to translate research into guidelines and practice. Alcohol Alcohol. 2004 Jul-Aug; 39(4):325-8. PMID: 15208165.
      Citations:    
    162. Thomas SE, Drobes DJ, Voronin K, Anton RF. Following alcohol consumption, nontreatment-seeking alcoholics report greater stimulation but similar sedation compared with social drinkers. J Stud Alcohol. 2004 May; 65(3):330-5. PMID: 15222589.
      Citations:    
    163. Myrick H, Anton RF, Li X, Henderson S, Drobes D, Voronin K, George MS. Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology. 2004 Feb; 29(2):393-402. PMID: 14679386.
      Citations:    
    164. Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D. Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl). 2004 Apr; 173(1-2):32-40. PMID: 14722705.
      Citations:    
    165. Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol. 2003 Dec; 23(6):553-62. PMID: 14624185.
      Citations:    
    166. Schilter B, Andersson C, Anton R, Constable A, Kleiner J, O'Brien J, Renwick AG, Korver O, Smit F, Walker R. Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem Toxicol. 2003 Dec; 41(12):1625-49. PMID: 14563389.
      Citations:    
    167. Nellissery M, Feinn RS, Covault J, Gelernter J, Anton RF, Pettinati H, Moak D, Mueller T, Kranzler HR. Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics. Alcohol Clin Exp Res. 2003 Sep; 27(9):1402-8. PMID: 14506400.
      Citations:    
    168. Allen JP, Anton R. Biomarkers as aids to identification of relapse in alcoholic patients. Recent Dev Alcohol. 2003; 16:25-38. PMID: 12638630.
      Citations:    
    169. Gastfriend DR, Rubin A, Sharon E, Turner WM, Anton RF, Donovan DM, Gorski T, Marlatt GA, Maisto S, Schultz TK, Shulman GD. New constructs and assessments for relapse and continued use potential in the ASAM Patient Placement Criteria. J Addict Dis. 2003; 22 Suppl 1:95-111. PMID: 15991592.
      Citations:    
    170. Anton RF, Swift RM. Current pharmacotherapies of alcoholism: a U.S. perspective. Am J Addict. 2003; 12(s1):s53-s68. PMID: 14972780.
      Citations:    
    171. Drobes DJ, Anton RF, Thomas SE, Voronin K. A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene. Neuropsychopharmacology. 2003 Apr; 28(4):755-64. PMID: 12655322.
      Citations:    
    172. Deas D, Roberts JS, Randall CL, Anton RF. Confirmatory analysis of the adolescent obsessive compulsive drinking scale (A-OCDS): a measure of 'craving' and problem drinking in adolescents/young adults. J Natl Med Assoc. 2002 Oct; 94(10):879-87. PMID: 12408692.
      Citations:    
    173. Rukstalis MR, Lynch KG, Oslin DW, Pettinati HM, Anderson SM, Volpicelli JR, Anton RF. Carbohydrate-deficient transferrin levels reflect heavy drinking in alcohol-dependent women seeking treatment. Alcohol Clin Exp Res. 2002 Oct; 26(10):1539-44. PMID: 12394287.
      Citations:    
    174. Shively CA, Williams JK, Laber-Laird K, Anton RF. Depression and coronary artery atherosclerosis and reactivity in female cynomolgus monkeys. Psychosom Med. 2002 Sep-Oct; 64(5):699-706. PMID: 12271100.
      Citations:    
    175. Anton RF, Lieber C, Tabakoff B. Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res. 2002 Aug; 26(8):1215-22. PMID: 12198396.
      Citations:    
    176. Lobstein A, Yepes Y, Um BH, Weniger B, Lugnier C, Anton R. Bioactive compounds from Leycesteria formosa. Pharmazie. 2002 Jun; 57(6):431-2. PMID: 12116886.
      Citations:    
    177. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF, Ballenger JC. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med. 2002 May; 17(5):349-55. PMID: 12047731.
      Citations:    
    178. Malcolm R, Myrick H, Roberts J, Wang W, Anton RF. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict. 2002; 11(2):141-50. PMID: 12028744.
      Citations:    
    179. Weniger B, Robledo S, Arango GJ, Deharo E, Aragón R, Muñoz V, Callapa J, Lobstein A, Anton R. Antiprotozoal activities of Colombian plants. J Ethnopharmacol. 2001 Dec; 78(2-3):193-200. PMID: 11694364.
      Citations:    
    180. DiMartini A, Day N, Lane T, Beisler AT, Dew MA, Anton R. Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease. Alcohol Clin Exp Res. 2001 Dec; 25(12):1729-33. PMID: 11781505.
      Citations:    
    181. Um BH, Weniger B, Lobstein A, Pouplin T, Polat M, Aragón R, Anton R. Triterpenoid saponins from Isertia pittieri. J Nat Prod. 2001 Dec; 64(12):1588-9. PMID: 11754623.
      Citations:    
    182. Anton RF. Naltrexone for alcohol dependence: comments on Morris et al. (2001). Addiction. 2001 Dec; 96(12):1855. PMID: 11784478.
      Citations:    
    183. Anton RF. Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here? Alcohol. 2001 Nov; 25(3):185-8. PMID: 11839464.
      Citations:    
    184. Anton RF, Dominick C, Bigelow M, Westby C. Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyltransferase. Clin Chem. 2001 Oct; 47(10):1769-75. PMID: 11568085.
      Citations:    
    185. Weniger B, Um BH, Valentin A, Estrada A, Lobstein A, Anton R, Maillé M, Sauvain M. Bioactive acridone alkaloids from Swinglea glutinosa. J Nat Prod. 2001 Sep; 64(9):1221-3. PMID: 11575960.
      Citations:    
    186. Myrick H, Henderson S, Anton RF. Utility of a new assay for carbohydrate-deficient transferrin (Biorad %CDT TIA) to monitor abstinence during a treatment outcome study. Alcohol Clin Exp Res. 2001 Sep; 25(9):1330-4. PMID: 11584153.
      Citations:    
    187. Johnson DE, Epstein JN, Waid LR, Latham PK, Voronin KE, Anton RF. Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder. Arch Clin Neuropsychol. 2001 Aug; 16(6):587-604. PMID: 14590156.
      Citations:    
    188. Um BH, Pouplin T, Lobstein A, Weniger B, Litaudon M, Anton R. Saponins from Strasburgeria robusta. Fitoterapia. 2001 Jun; 72(5):591-3. PMID: 11429265.
      Citations:    
    189. Mann K, Agartz I, Harper C, Shoaf S, Rawlings RR, Momenan R, Hommer DW, Pfefferbaum A, Sullivan EV, Anton RF, Drobes DJ, George MS, Bares R, Machulla HJ, Mundle G, Reimold M, Heinz A. Neuroimaging in alcoholism: ethanol and brain damage. Alcohol Clin Exp Res. 2001 May; 25(5 Suppl ISBRA):104S-109S. PMID: 11391058.
      Citations:    
    190. Lobstein A, Brenne X, Feist E, Metz N, Weniger B, Anton R. Quantitative determination of naphthoquinones of Impatiens species. Phytochem Anal. 2001 May-Jun; 12(3):202-5. PMID: 11705027.
      Citations:    
    191. Lakshman R, Tsutsumi M, Ghosh P, Takase S, Anni H, Nikolaeva O, Israel Y, Anton RF, Lesch OM, Helender A, Eriksson G, Jeppson JO, Marmillot P, Rao MN. Alcohol biomarkers: clinical significance and biochemical basis. Alcohol Clin Exp Res. 2001 May; 25(5 Suppl ISBRA):67S-70S. PMID: 11391052.
      Citations:    
    192. George MS, Anton RF, Bloomer C, Teneback C, Drobes DJ, Lorberbaum JP, Nahas Z, Vincent DJ. Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues. Arch Gen Psychiatry. 2001 Apr; 58(4):345-52. PMID: 11296095.
      Citations:    
    193. Deas D, Roberts J, Randall C, Anton R. Adolescent Obsessive-Compulsive Drinking Scale: an assessment tool for problem drinking. J Natl Med Assoc. 2001 Mar; 93(3):92-103. PMID: 12656441.
      Citations:    
    194. Flannery BA, Roberts AJ, Cooney N, Swift RM, Anton RF, Rohsenow DJ. The role of craving in alcohol use, dependence, and treatment. Alcohol Clin Exp Res. 2001 Feb; 25(2):299-308. PMID: 11236847.
      Citations:    
    195. Anton RF, Moak DH, Latham PK, Waid LR, Malcolm RJ, Dias JK, Roberts JS. Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism. J Clin Psychopharmacol. 2001 Feb; 21(1):72-7. PMID: 11199951.
      Citations:    
    196. Anton RF. Pharmacologic approaches to the management of alcoholism. J Clin Psychiatry. 2001; 62 Suppl 20:11-7. PMID: 11584870.
      Citations:    
    197. Brouette T, Anton R. Clinical review of inhalants. Am J Addict. 2001; 10(1):79-94. PMID: 11268830.
      Citations:    
    198. Weniger B, Aragon R, Deharo E, Bastida J, Codina C, Lobstein A, Anton R. Antimalarial constituents from Guatteria amplifolia. Pharmazie. 2000 Nov; 55(11):867-8. PMID: 11126013.
      Citations:    
    199. Malcolm R, Roberts JS, Wang W, Myrick H, Anton RF. Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol. 2000 Nov; 22(3):159-64. PMID: 11163123.
      Citations:    
    200. Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol. 2000 Nov-Dec; 35(6):587-93. PMID: 11093966.
      Citations:    
    201. Anton RF. Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale. Addiction. 2000 Aug; 95 Suppl 2:S211-7. PMID: 11002915.
      Citations:    
    202. Malcolm R, Kajdasz DK, Herron J, Anton RF, Brady KT. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000 Aug 01; 60(2):161-8. PMID: 10940543.
      Citations:    
    203. Deas D, Randall CL, Roberts JS, Anton RF. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Hum Psychopharmacol. 2000 Aug; 15(6):461-469. PMID: 12404308.
      Citations:    
    204. Frantz M, Jung ML, Ribereau-Gayon G, Anton R. Modulation of mistletoe (Viscum album L.) lectins cytotoxicity by carbohydrates and serum glycoproteins. Arzneimittelforschung. 2000 May; 50(5):471-8. PMID: 10858875.
      Citations:    
    205. Drobes DJ, Anton RF. Drinking in alcoholics following an alcohol challenge research protocol. J Stud Alcohol. 2000 Mar; 61(2):220-4. PMID: 10757131.
      Citations:    
    206. Malcolm R, Herron JE, Anton RF, Roberts J, Moore J. Recurrent detoxification may elevate alcohol craving as measured by the Obsessive Compulsive Drinking scale. Alcohol. 2000 Feb; 20(2):181-5. PMID: 10719797.
      Citations:    
    207. Myrick H, Anton RF. Clinical management of alcohol withdrawal. CNS Spectr. 2000 Feb; 5(2):22-32. PMID: 18296996.
      Citations:    
    208. Babor TF, Steinberg K, Anton R, Del Boca F. Talk is cheap: measuring drinking outcomes in clinical trials. J Stud Alcohol. 2000 Jan; 61(1):55-63. PMID: 10627097.
      Citations:    
    209. Metz N, Lobstein A, Schneider Y, Gossé F, Schleiffer R, Anton R, Raul F. Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract. Nutr Cancer. 2000; 38(1):60-4. PMID: 11341046.
      Citations:    
    210. Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry. 1999 Nov; 156(11):1758-64. PMID: 10553740.
      Citations:    
    211. Roberts JS, Anton RF, Latham PK, Moak DH. Factor structure and predictive validity of the Obsessive Compulsive Drinking Scale. Alcohol Clin Exp Res. 1999 Sep; 23(9):1484-91. PMID: 10512314.
      Citations:    
    212. Anton RF. Alcohol craving--a renaissance. Alcohol Clin Exp Res. 1999 Aug; 23(8):1287-8. PMID: 10470969.
      Citations:    
    213. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 16223062.
      Citations:    
    214. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 2088115.
      Citations:    
    215. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 8947235.
      Citations:    
    216. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 26997195.
      Citations:    
    217. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 28471501.
      Citations:    
    218. George MS, Tenebäck CC, Malcolm RJ, Moore J, Stallings LE, Spicer KM, Anton RF, Ballenger JC. Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period. Alcohol Clin Exp Res. 1999 Jun; 23(6):1077-84. PMID: 10397294.
      Citations:    
    219. Horner MD, Waid LR, Johnson DE, Latham PK, Anton RF. The relationship of cognitive functioning to amount of recent and lifetime alcohol consumption in outpatient alcoholics. Addict Behav. 1999 May-Jun; 24(3):449-53. PMID: 10400285.
      Citations:    
    220. Lenne-Gouverneur AF, Lobstein A, Haan-Archipoff G, Duportail G, Anton R, Kuhry JG. Interactions of the monomeric and dimeric flavones apigenin and amentoflavone with the plasma membrane of L929 cells; a fluorescence study. Mol Membr Biol. 1999 Apr-Jun; 16(2):157-65. PMID: 10417980.
      Citations:    
    221. Allen JP, Sillamaukee P, Anton R. Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism. Alcohol Clin Exp Res. 1999 Jan; 23(1):115-20. PMID: 10029211.
      Citations:    
    222. Anton RF. What is craving? Models and implications for treatment. Alcohol Res Health. 1999; 23(3):165-73. PMID: 10890811.
      Citations:    
    223. Malcolm R, Anton RF, Conrad SE, Sutherland S. Carbohydrate-deficient transferrin and alcohol use in medical examiner cases. Alcohol. 1999 Jan; 17(1):7-11. PMID: 9895031.
      Citations:    
    224. Andriambeloson E, Magnier C, Haan-Archipoff G, Lobstein A, Anton R, Beretz A, Stoclet JC, Andriantsitohaina R. Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr. 1998 Dec; 128(12):2324-33. PMID: 9868177.
      Citations:    
    225. Anton RF, Stout RL, Roberts JS, Allen JP. The effect of drinking intensity and frequency on serum carbohydrate-deficient transferrin and gamma-glutamyl transferase levels in outpatient alcoholics. Alcohol Clin Exp Res. 1998 Oct; 22(7):1456-62. PMID: 9802528.
      Citations:    
    226. Yeastedt J, La Grange L, Anton RF. Female alcoholic outpatients and female college students: a correlational study of self-reported alcohol consumption and carbohydrate-deficient transferrin levels. J Stud Alcohol. 1998 Sep; 59(5):555-9. PMID: 9718108.
      Citations:    
    227. Moak DH, Anton RF, Latham PK. Further validation of the Obsessive-Compulsive Drinking Scale (OCDS). Relationship to alcoholism severity. Am J Addict. 1998; 7(1):14-23. PMID: 9522003.
      Citations:    
    228. Myrick H, Anton RF. Treatment of alcohol withdrawal. Alcohol Health Res World. 1998; 22(1):38-43. PMID: 15706731.
      Citations:    
    229. Johnson DE, Waid LR, Anton RF. Childhood hyperactivity, gender, and Cloninger's personality dimensions in alcoholics. Addict Behav. 1997 Sep-Oct; 22(5):649-53. PMID: 9347067.
      Citations:    
    230. Anton RF, Kranzler HR, McEvoy JP, Moak DH, Bianca R. A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal. Psychopharmacology (Berl). 1997 May; 131(2):123-9. PMID: 9201799.
      Citations:    
    231. Shively CA, Laber-Laird K, Anton RF. Behavior and physiology of social stress and depression in female cynomolgus monkeys. Biol Psychiatry. 1997 Apr 15; 41(8):871-82. PMID: 9099414.
      Citations:    
    232. Allen JP, Fertig JB, Litten RZ, Sillanaukee P, Anton RF. Proposed recommendations for research on biochemical markers for problematic drinking. Alcohol Clin Exp Res. 1997 Apr; 21(2):244-7. PMID: 9113259.
      Citations:    
    233. Ribéreau-Gayon G, Jung ML, Frantz M, Anton R. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anticancer Drugs. 1997 Apr; 8 Suppl 1:S3-8. PMID: 9179359.
      Citations:    
    234. Ribéreau-Gayon G, Dumont S, Muller C, Jung ML, Poindron P, Anton R. Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes. Cancer Lett. 1996 Dec 03; 109(1-2):33-8. PMID: 9020900.
      Citations:    
    235. Anton RF. Pharmacotherapy of alcoholism--10 years of progress. Alcohol Clin Exp Res. 1996 Nov; 20(8 Suppl):172A-175A. PMID: 8947259.
      Citations:    
    236. Johnson BA, Jasinski DR, Galloway GP, Kranzler H, Weinreib R, Anton RF, Mason BJ, Bohn MJ, Pettinati HM, Rawson R, Clyde C. Ritanserin in the treatment of alcohol dependence--a multi-center clinical trial. Ritanserin Study Group. Psychopharmacology (Berl). 1996 Nov; 128(2):206-15. PMID: 8956382.
      Citations:    
    237. Anton RF. New methodologies for pharmacological treatment trials for alcohol dependence. Alcohol Clin Exp Res. 1996 Oct; 20(7 Suppl):3A-9A. PMID: 8904988.
      Citations:    
    238. Adinoff B, Anton R, Linnoila M, Guidotti A, Nemeroff CB, Bissette G. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence. Neuropsychopharmacology. 1996 Sep; 15(3):288-95. PMID: 8873112.
      Citations:    
    239. Anton RF, Moak DH, Latham P. Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study. Alcohol Clin Exp Res. 1996 Aug; 20(5):841-6. PMID: 8865958.
      Citations:    
    240. Anton RF. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions. Alcohol Alcohol Suppl. 1996 Mar; 31(1):43-53. PMID: 9845037.
      Citations:    
    241. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 1996 Mar; 53(3):225-31. PMID: 8611059.
      Citations:    
    242. Moak DH, Anton RF. Alcohol-related seizures and the kindling effect of repeated detoxifications: the influence of cocaine. Alcohol Alcohol. 1996 Mar; 31(2):135-43. PMID: 8737008.
      Citations:    
    243. Anton RF. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions. Alcohol Alcohol. 1996 Mar; 31 Suppl 1:43-53. PMID: 8737000.
      Citations:    
    244. Oulad-Ali A, Kirchner V, Lobstein A, Weniger B, Anton R, Guillaume D, Charrouf Z. Structure elucidation of three triterpene glycosides from the trunk of Argania spinosa. J Nat Prod. 1996 Feb; 59(2):193-5. PMID: 8991953.
      Citations:    
    245. Weniger B, Rafik W, Bastida J, Quirion JC, Anton R. Indole alkaloids from Antirhea lucida. Planta Med. 1995 Dec; 61(6):569-70. PMID: 17238112.
      Citations:    
    246. Englert J, Weniger B, Lobstein A, Anton R, Krempp E, Guillaume D, Leroy Y. Triterpenoid saponins from Mimosa pigra. J Nat Prod. 1995 Aug; 58(8):1265-9. PMID: 7595593.
      Citations:    
    247. Bean P, Sutphin MS, Liu Y, Anton R, Reynolds TB, Shoenfeld Y, Peter JB. Carbohydrate-deficient transferrin and false-positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies. Clin Chem. 1995 Jun; 41(6 Pt 1):858-61. PMID: 7768004.
      Citations:    
    248. Brady KT, Sonne SC, Anton R, Ballenger JC. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995 Mar; 56(3):118-21. PMID: 7883730.
      Citations:    
    249. La Grange L, Anton RF, Garcia S, Herrbold C. Carbohydrate-deficient transferrin levels in a female population. Alcohol Clin Exp Res. 1995 Feb; 19(1):100-3. PMID: 7771634.
      Citations:    
    250. Anton RF, Moak DH, Latham P. The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res. 1995 Feb; 19(1):92-9. PMID: 7771669.
      Citations:    
    251. Weniger B, Italiano L, Beck JP, Bastida J, Bergoñon S, Codina C, Lobstein A, Anton R. Cytotoxic activity of Amaryllidaceae alkaloids. Planta Med. 1995 Feb; 61(1):77-9. PMID: 7701000.
      Citations:    
    252. Kane DJ, Ord T, Anton R, Bredesen DE. Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res. 1995 Feb 01; 40(2):269-75. PMID: 7745620.
      Citations:    
    253. Anton RF. Disulfiram Treatment of Alcoholism. Alcohol Health Res World. 1995; 19(1):56-57. PMID: 31798091.
      Citations:    
    254. Anton RF, Kranzler HR, Meyer RE. Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. Clin Neurosci. 1995; 3(3):145-54. PMID: 8612059.
      Citations:    
    255. Nicolas G, Oulad-Ali A, Guillaume D, Lobstein A, Weniger B, Anton R. Triterpenoid saponins from the root of Sideroxylon foetidissimum. Phytochemistry. 1995 Jan; 38(1):225-8. PMID: 7766055.
      Citations:    
    256. Kranzler HR, Anton RF. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. J Consult Clin Psychol. 1994 Dec; 62(6):1116-26. PMID: 7860810.
      Citations:    
    257. Connors GJ, Allen JP, Cooney NL, DiClemente CC, Tonigan JS, Anton RF. Assessment issues and strategies in alcoholism treatment matching research. J Stud Alcohol Suppl. 1994 Dec; 12:92-100. PMID: 7723004.
      Citations:    
    258. Fuller RK, Mattson ME, Allen JP, Randall CL, Anton RF, Babor TF. Multisite clinical trials in alcoholism treatment research: organizational, methodological and management issues. J Stud Alcohol Suppl. 1994 Dec; 12:30-7. PMID: 7722995.
      Citations:    
    259. Babor TF, Longabaugh R, Zweben A, Fuller RK, Stout RL, Anton RF, Randall CL. Issues in the definition and measurement of drinking outcomes in alcoholism treatment research. J Stud Alcohol Suppl. 1994 Dec; 12:101-11. PMID: 7722986.
      Citations:    
    260. Burch EA, Anton RF, Carson WH. Mood congruent and incongruent psychotic depressions: are they the same? J Affect Disord. 1994 Aug; 31(4):275-80. PMID: 7989642.
      Citations:    
    261. Allen JP, Litten RZ, Anton RF, Cross GM. Carbohydrate-deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res. 1994 Aug; 18(4):799-812. PMID: 7978088.
      Citations:    
    262. Jiang Y, Weniger B, Quirion JC, Muller C, Anton R. 3alpha,5alpha-Tetrahydrodeoxycordifoline from Guettarda ovalifolia. Planta Med. 1994 Jun; 60(3):294. PMID: 17236053.
      Citations:    
    263. La Grange L, Anton RF, Crow H, Garcia S. A correlational study of carbohydrate-deficient transferrin values and alcohol consumption among Hispanic college students. Alcohol Clin Exp Res. 1994 Jun; 18(3):653-6. PMID: 7943671.
      Citations:    
    264. Anton RF, Moak DH. Carbohydrate-deficient transferrin and gamma-glutamyltransferase as markers of heavy alcohol consumption: gender differences. Alcohol Clin Exp Res. 1994 Jun; 18(3):747-54. PMID: 7943686.
      Citations:    
    265. Oulad-Ali A, Guillaume D, Weniger B, Jiang Y, Anton R. Mabiosides C-E: triterpenoid saponins from the bark of Colubrina elliptica. Phytochemistry. 1994 May; 36(2):445-8. PMID: 7764881.
      Citations:    
    266. Englert J, Jiang Y, Cabalion P, Oulad-Ali A, Anton R. C-Glycosoylflavones from Aerial Parts of Mimosa pudica. Planta Med. 1994 Apr; 60(2):194. PMID: 17236039.
      Citations:    
    267. Jiang Y, Ali AO, Guillaume D, Weniger B, Anton R. Triterpenoid saponins from the root of Sideroxylon cubense. Phytochemistry. 1994 Mar; 35(4):1013-5. PMID: 7764627.
      Citations:    
    268. Anton R, Bean P. Two methods for measuring carbohydrate-deficient transferrin in inpatient alcoholics and healthy controls compared. Clin Chem. 1994 Mar; 40(3):364-8. PMID: 8131268.
      Citations:    
    269. Anton RF. Medications for Treating Alcoholism. Alcohol Health Res World. 1994; 18(4):265-271. PMID: 31798036.
      Citations:    
    270. Lydiard RB, Anton RF, Cunningham T. Interactions between sertraline and tricyclic antidepressants. Am J Psychiatry. 1993 Jul; 150(7):1125-6. PMID: 8317590.
      Citations:    
    271. Anton RF, Burch EA. Response of psychotic depression subtypes to pharmacotherapy. J Affect Disord. 1993 Jun; 28(2):125-31. PMID: 8354768.
      Citations:    
    272. Anton R, Jiang Y, Weniger B, Beck JP, Rivier L. Pharmacognosy of Mimosa tenuiflora (Willd.) Poiret. J Ethnopharmacol. 1993 Mar; 38(2-3):153-7. PMID: 8510463.
      Citations:    
    273. Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A. A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res. 1992 Dec; 16(6):1007-13. PMID: 1335217.
      Citations:    
    274. Dietrich JB, Ribéreau-Gayon G, Jung ML, Franz H, Beck JP, Anton R. Identity of the N-terminal sequences of the three A chains of mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins. Anticancer Drugs. 1992 Oct; 3(5):507-11. PMID: 1450445.
      Citations:    
    275. Randall CL, Anton RF, Becker HC, Hale RL, Ekblad U. Aspirin dose-dependently reduces alcohol-induced birth defects and prostaglandin E levels in mice. Teratology. 1991 Nov; 44(5):521-9. PMID: 1771594.
      Citations:    
    276. Lobstein A, Rietsch-Jako L, Haag-Berrurier M, Anton R. Seasonal Variations of the Flavonoid Content from Ginkgo biloba Leaves. Planta Med. 1991 Oct; 57(5):430-3. PMID: 17226181.
      Citations:    
    277. Abd el Hafiz MA, Ramadan MA, Jung ML, Beck JP, Anton R. Cytotoxic activity of Amaryllidaceae alkaloids from Crinum augustum and Crinum bulbispermum. Planta Med. 1991 Oct; 57(5):437-9. PMID: 1798796.
      Citations:    
    278. Randall CL, Becker HC, Anton RF. Effect of ibuprofen on alcohol-induced teratogenesis in mice. Alcohol Clin Exp Res. 1991 Aug; 15(4):673-7. PMID: 1928642.
      Citations:    
    279. Johnston AL, Thevos AK, Randall CL, Anton RF. Increased severity of alcohol withdrawal in in-patient alcoholics with a co-existing anxiety diagnosis. Br J Addict. 1991 Jun; 86(6):719-25. PMID: 1878622.
      Citations:    
    280. Adjibadé Y, Hue B, Pelhate M, Anton R. Action of calycanthine on nervous transmission in cockroach central nervous system. Planta Med. 1991 Apr; 57(2):99-101. PMID: 1653964.
      Citations:    
    281. Jiang YL, Massiot G, Lavaud C, Teulon JM, Guéchot C, Haag-Berrurier M, Anton R. Triterpenoid glycosides from the bark of Mimosa tenuiflora. Phytochemistry. 1991; 30(7):2357-60. PMID: 1367651.
      Citations:    
    282. Kellner CH, Grice DE, Pickrel SG, Anton RF, Joffe RT. Normalization of Augmented TRH Stimulation Test in Response to ECT. Convuls Ther. 1991; 7(2):125-128. PMID: 11941112.
      Citations:    
    283. Brady K, Anton R, Ballenger JC, Lydiard RB, Adinoff B, Selander J. Cocaine abuse among schizophrenic patients. Am J Psychiatry. 1990 Sep; 147(9):1164-7. PMID: 2386250.
      Citations:    
    284. Anton RF, Burch EA. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry. 1990 Sep; 147(9):1203-8. PMID: 2201223.
      Citations:    
    285. Becker HC, Anton RF. Valproate potentiates and picrotoxin antagonizes the anxiolytic action of ethanol in a nonshock conflict task. Neuropharmacology. 1990 Sep; 29(9):837-43. PMID: 1981382.
      Citations:    
    286. Anton R, Beretz A. [Flavonoids: antithrombotic agents or nutrients?]. Bull Acad Natl Med. 1990 Jun-Jul; 174(6):709-14; discussion 714-7. PMID: 2271980.
      Citations:    
    287. Adjibadé Y, Saad H, Kuballa B, Beck JP, Sévenet T, Cabalion P, Anton R. In vitro cytotoxicity of polyindolenine alkaloids on rat hepatoma cell lines. Structure activity relationships. J Ethnopharmacol. 1990 May; 29(2):127-36. PMID: 2374427.
      Citations:    
    288. Adjibadé Y, Saad H, Sévenet T, Kuballa B, Quirion JC, Anton R. New Polyindolenine Alkaloids from Calycodendron milnei. Planta Med. 1990 Apr; 56(2):212-5. PMID: 17221397.
      Citations:    
    289. Keochanthala-Bounthanh C, Haag-Berrurier M, Beck JP, Anton R. Effects of thiol compounds versus the cytotoxicity of valepotriates on cultured hepatoma cells. Planta Med. 1990 Apr; 56(2):190-2. PMID: 2353067.
      Citations:    
    290. Willenbring ML, Anton RF, Spring WD, Shafer RB, Dorus W. Thyrotropin and prolactin response to thyrotropin-releasing hormone in depressed and nondepressed alcoholic men. Biol Psychiatry. 1990 Jan 01; 27(1):31-8. PMID: 2105105.
      Citations:    
    291. Anton RF, Becker HC, Randall CL. Ethanol increases PGE and thromboxane production in mouse pregnant uterine tissue. Life Sci. 1990; 46(16):1145-53. PMID: 2342401.
      Citations:    
    292. Adjibadé Y, Kuballa B, Cabalion P, Jung ML, Beck JP, Anton R. Cytotoxicity on human leukemic and rat hepatoma cell lines of alkaloid extracts of Psychotria forsteriana. Planta Med. 1989 Dec; 55(6):567-8. PMID: 2616674.
      Citations:    
    293. Dorus W, Ostrow DG, Anton R, Cushman P, Collins JF, Schaefer M, Charles HL, Desai P, Hayashida M, Malkerneker U, et al. Lithium treatment of depressed and nondepressed alcoholics. JAMA. 1989 Sep 22-29; 262(12):1646-52. PMID: 2504944.
      Citations:    
    294. Anton RF, Ballenger JC, Lydiard RB, Laraia MT, Howell EF, Gold PW. CSF prostaglandin-E in agoraphobia with panic attacks. Biol Psychiatry. 1989 Jul; 26(3):257-64. PMID: 2545288.
      Citations:    
    295. Malcolm R, Ballenger JC, Sturgis ET, Anton R. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May; 146(5):617-21. PMID: 2653057.
      Citations:    
    296. Kathol RG, Anton R, Noyes R, Gehris T. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder. Biol Psychiatry. 1989 Apr 01; 25(7):873-8. PMID: 2720002.
      Citations:    
    297. Brady KT, Anton RF. The thyroid axis and desipramine treatment in depression. Biol Psychiatry. 1989 Mar 15; 25(6):703-9. PMID: 2493818.
      Citations:    
    298. Becker HC, Anton RF. The benzodiazepine receptor inverse agonist RO15-4513 exacerbates, but does not precipitate, ethanol withdrawal in mice. Pharmacol Biochem Behav. 1989 Jan; 32(1):163-7. PMID: 2543989.
      Citations:    
    299. Randall CL, Anton RF, Becker HC, White NM. Role of prostaglandins in alcohol teratogenesis. Ann N Y Acad Sci. 1989; 562:178-82. PMID: 2742275.
      Citations:    
    300. Anton RF, Randall CL, Becker HC. PGE measurement in mouse embryos and uterine/embryo tissue. Prostaglandins. 1988 Dec; 36(6):835-46. PMID: 3244834.
      Citations:    
    301. Randall CL, Anton RF, Becker HC. Role of alcohol-induced hypothermia in mediating the teratogenic effects of alcohol in C57BL/6J mice. Alcohol Clin Exp Res. 1988 Jun; 12(3):412-6. PMID: 3044172.
      Citations:    
    302. Victoire C, Haag-Berrurier M, Lobstein-Guth A, Balz JP, Anton R. Isolation of Flavonol Glycosides from Ginkgo biloba Leaves. Planta Med. 1988 Jun; 54(3):245-7. PMID: 17265263.
      Citations:    
    303. Brown ME, Anton RF, Malcolm R, Ballenger JC. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry. 1988 Mar 01; 23(5):507-14. PMID: 3345323.
      Citations:    
    304. Anton R. Flavonoids and traditional medicine. Prog Clin Biol Res. 1988; 280:423-39. PMID: 3174704.
      Citations:    
    305. Becker HC, Anton RF, Randall CL. Stereotypic wall climbing in mice during ethanol withdrawal: a new measure of physical dependence. Alcohol. 1987 Nov-Dec; 4(6):443-7. PMID: 3435633.
      Citations:    
    306. Assaf MH, Ali AA, Makboul MA, Beck JP, Anton R. Preliminary study of phenolic glycosides from Origanum majorana; quantitative estimation of arbutin; cytotoxic activity of hydroquinone. Planta Med. 1987 Aug; 53(4):343-5. PMID: 3671554.
      Citations:    
    307. Randall CL, Anton RF, Becker HC. Effect of indomethacin on alcohol-induced morphological anomalies in mice. Life Sci. 1987 Jul 20; 41(3):361-9. PMID: 3600183.
      Citations:    
    308. Randall CL, Anton RF, Becker HC. Alcohol, pregnancy, and prostaglandins. Alcohol Clin Exp Res. 1987 Feb; 11(1):32-6. PMID: 3551661.
      Citations:    
    309. Anton RF, Randall CL. Central nervous system prostaglandins and ethanol. Alcohol Clin Exp Res. 1987 Feb; 11(1):10-8. PMID: 3105343.
      Citations:    
    310. Anton RF. Urinary free cortisol in psychotic depression. Biol Psychiatry. 1987 Jan; 22(1):24-34. PMID: 3790638.
      Citations:    
    311. Roth A, Kuballa B, Bounthanh C, Cabalion P, Sévenet T, Beck JP, Anton R. Cytotoxic activity of polyindoline alkaloids of Psychotria forsteriana (Rubiaceae) (1). Planta Med. 1986 Dec; (6):450-3. PMID: 3494261.
      Citations:    
    312. Archipoff G, Linder C, Lobstein-Guth A, Anton R. Bioconversion of Morphine by Cell Suspensions of Ginkgo biloba Growing in vitro. Planta Med. 1986 Dec; (6):515-6. PMID: 17345446.
      Citations:    
    313. Adjibade Y, Kuballa B, Cabalion P, Anton R. A New Alkaloid from Psychotria forsteriana. Planta Med. 1986 Dec; (6):523. PMID: 17345462.
      Citations:    
    314. Anton RF, Waid LR, Fossey M, AuBuchon P. Case report of carbamazepine treatment of organic brain syndrome with psychotic features. J Clin Psychopharmacol. 1986 Aug; 6(4):232-4. PMID: 3734143.
      Citations:    
    315. Weniger B, Rouzier M, Daguilh R, Foucaud J, Robineau L, Anton R. [Traditional medicine in the Central Plateau of Haiti. 1. Study of the traditional therapeutic system in a rural socio-cultural area]. J Ethnopharmacol. 1986 Jul; 17(1):1-11. PMID: 3762192.
      Citations:    
    316. Weniger B, Rouzier M, Daguilh R, Henrys D, Henrys JH, Anton R. [Traditional medicine in the Central Plateau of Haiti. 2. Ethnopharmacologic inventory]. J Ethnopharmacol. 1986 Jul; 17(1):13-30. PMID: 3762193.
      Citations:    
    317. Becker HC, Randall CL, Anton RF. Pre-pregnancy alcohol experience attenuates typical decrease in gestational alcohol consumption in mice. Alcohol. 1986 Jan-Feb; 3(1):19-22. PMID: 3964433.
      Citations:    
    318. Becker HC, Anton RF, De Trana C, Randall CL. Sensitivity to ethanol in female mice: effects of ovariectomy and strain. Life Sci. 1985 Oct 07; 37(14):1293-300. PMID: 4046734.
      Citations:    
    319. Beretz A, Roth-Georger A, Corre G, Kuballa B, Anton R, Cazenave JP. Polyindolinic Alkaloids from Psychotria forsteriana. Potent Inhibitors of the Aggregation of Human Platelets. Planta Med. 1985 Aug; 51(4):300-3. PMID: 17340518.
      Citations:    
    320. Johnson GC, Anton RF. Delusions of parasitosis: differential diagnosis and treatment. South Med J. 1985 Aug; 78(8):914-8. PMID: 4023781.
      Citations:    
    321. Anton RF, Paladino JA, Morton A, Thomas RW. Effect of acute alcohol consumption on lithium kinetics. Clin Pharmacol Ther. 1985 Jul; 38(1):52-5. PMID: 4006376.
      Citations:    
    322. Amellal M, Bronner C, Briancon F, Haag M, Anton R, Landry Y. Inhibition of mast cell histamine release by flavonoids and biflavonoids. Planta Med. 1985 Feb; 51(1):16-20. PMID: 17340391.
      Citations:    
    323. Randall CL, Anton RF. Aspirin reduces alcohol-induced prenatal mortality and malformations in mice. Alcohol Clin Exp Res. 1984 Nov-Dec; 8(6):513-5. PMID: 6393800.
      Citations:    
    324. Wallis CJ, Anton RF, Randall CL. Adrenalectomy reduces alcohol-stimulated activity: blood and brain alcohol content. Pharmacol Biochem Behav. 1984 Jun; 20(6):883-6. PMID: 6540448.
      Citations:    
    325. Briançon-Scheid F, Lobstein-Guth A, Anton R. HPLC Separation and Quantitative Determination of Biflavones in Leaves from Ginkgo biloba. Planta Med. 1983 Dec; 49(12):204-7. PMID: 17405053.
      Citations:    
    326. Anton RF, Sexauer JD, Randall CL. Amoxapine elevates serum prolactin in depressed men. J Affect Disord. 1983 Nov; 5(4):305-10. PMID: 6229562.
      Citations:    
    327. Bounthanh C, Richert L, Beck JP, Haag-Berrurier M, Anton R. The action of valepotriates on the synthesis of DNA and proteins of cultured hepatoma cells. Planta Med. 1983 Nov; 49(3):138-42. PMID: 6657786.
      Citations:    
    328. Anton RF, Sexauer JD. Efficacy of amoxapine in psychotic depression. Am J Psychiatry. 1983 Oct; 140(10):1344-7. PMID: 6624968.
      Citations:    
    329. Anton RF, Wallis C, Randall CL. In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins. 1983 Sep; 26(3):421-9. PMID: 6658001.
      Citations:    
    330. Johnson GC, Anton RF. Pimozide in delusions of parasitosis. J Clin Psychiatry. 1983 Jun; 44(6):233. PMID: 6853463.
      Citations:    
    331. Randall CL, Hughes SS, Williams CK, Anton RF. Effect of prenatal alcohol exposure on consumption of alcohol and alcohol-induced sleep time in mice. Pharmacol Biochem Behav. 1983; 18 Suppl 1:325-9. PMID: 6685299.
      Citations:    
    332. Anton RF, Randall CL, Williams CK, Hoffmeyer GE. Inhibition of prostaglandin synthesis by indomethacin does not affect alcohol consumption in inbred mice. Alcohol Clin Exp Res. 1983; 7(4):386-8. PMID: 6362463.
      Citations:    
    333. Weniger B, Haag-Berrurier M, Anton R. Plants of Haiti used as antifertility agents. J Ethnopharmacol. 1982 Jul; 6(1):67-84. PMID: 7109665.
      Citations:    
    334. Murburg M, Anton RF, Nelson JC, Jatlow PI. Noninvasive measurement of cardiac ejection fraction during desipramine treatment. Psychosomatics. 1982 Jul; 23(7):759-61. PMID: 7122806.
      Citations:    
    335. Anton RF, Hogan I, Jalali B, Riordan CE, Kleber HD. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug Alcohol Depend. 1981 Sep; 8(2):157-68. PMID: 7318681.
      Citations:    
    336. Guth A, Briançon-Scheid F, Haag-Berrurier M, Anton R. [Analyse qualitative et quantitative des terpènes de Ginkgo biloba par HPLC.]. Planta Med. 1981 Jun; 42(6):129-30. PMID: 17401929.
      Citations:    
    337. Bounthanh C, Bergmann C, Beck JP, Haag-Berrurier M, Anton R. Valepotriates, a new class of cytotoxic and antitumor agents. Planta Med. 1981 Jan; 41(1):21-8. PMID: 7232547.
      Citations:    
    338. Anton RF. Linoleic acid in the treatment of lithium toxicity and familial tremor. Prostaglandins Med. 1980 Oct; 5(4):321-2. PMID: 7443876.
      Citations:    
    339. Schroeder G, Rohmer M, Beck JP, Anton R. Cytotoxic activity of 6,20-epoxylathyrol and its aliphatic diesters. Planta Med. 1979 Mar; 35(3):235-41. PMID: 432301.
      Citations:    
    Anton's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (870)
    Explore
    _
    Co-Authors (45)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _